Monoclonal antibodies targeting small airways: a new perspective for biological therapies in severe asthma
Small airway dysfunction (SAD) in asthma is characterized by the inflammation and
narrowing of airways with less of 2 mm in diameter between generations 8 and 23 of the …
narrowing of airways with less of 2 mm in diameter between generations 8 and 23 of the …
Early benefit of mepolizumab on small airways in severe asthma: insights from IMPOSE study
OS Kotsiou, P Kirgou, D Siachpazidou… - ERJ Open …, 2024 - publications.ersnet.org
Background Severe eosinophilic asthma adversely affects small airway function, but
effective therapeutic options are limited. The IMPOSE trial (NCT05147155) assessed the …
effective therapeutic options are limited. The IMPOSE trial (NCT05147155) assessed the …